Recently an increase in the incidence of mucormycosis is noticed in COVID-19 cases. The main aim of this
study is to present our experience of rhino-orbito-cerebral mucormycosis in COVID-19 patients and
thereby aid its early diagnosis and treatment. This is a prospective study of 12 cases diagnosed as Rhino-orbito-cerebral
mucormycosis . Presentation of mucormycosis in COVID-19, their temporal association and outcome of treatment was studied.
Pre-existing comorbidities were seen in 91.67% patients, Diabetes Mellitus (83.33%). Previous history of COVID-19 infection and
treatment for the same in 41.67% cases, concomitant infection in 16.67% and asymptomatic undiagnosed covid (antibodies
positive) was detected in 41.67%. All patients showed improvement in general and nasal condition (100%). Early diagnosis is
must.
Prevalence of Delayed Gastric Emptying in Diabetic Patients and Relationship to Dyspeptic Symptoms: A prospective study in unselected diabetic patients